Emerging markets lead in new product launches.

Despite rising inflation and the pandemic, Asian investors will increase investment in the healthcare and technology sectors, according to a UBS GWM survey.
This week FSA presents a quick comparison of two Greater China equities products: the Allianz All China Equity Fund and the BNP Paribas China Equity Classic.
Female investors tend to align investments with values, a BNY Mellon Investment Management report finds.
An increasing number of new ESG funds were launched in Asia during 2021, Cerulli report shows.
FSA compares two China equity products: the Allianz China A Shares Fund and the FSSA Greater China Growth Fund.
Morningstar adjusts its onshore China fund categories amid strong product growth and regulatory changes.
This week FSA presents a quick comparison of two North American Equity products: the JP Morgan US Growth Fund and the Morgan Stanley US Growth Fund.
Net assets of foreign equity funds now make up 18% of the industry.
Actively managed equity funds dominate China’s sustainable assets, data shows.
Part of the Mark Allen Group.